Our Story | Our Journey | Core Mission | Company Value

Our Story

Founded in 2011, LePure Biotech specializes in single-use systems and consumables for the biopharmaceutical industry. We offer reliable and high-quality bioprocessing solutions with vertically integrated manufacturing from in-house film extrusion to final product assembly, ensuring quality, consistency, and control.

With R&D and commercial operations across the U.S., South China, and Korea, our global footprint enables faster lead times and greater responsiveness, keeping your projects on track in today’s fast-paced market.

Company Highlights

4

Proprietary Consumables Materials

200+

Patents

3000+

Customers In 30+ countries

14yrs

In Business

Our Journey

2011

Founded in 2011, the company began by developing single-use bioprocess technologies to serve biotech and pharmaceutical clients.

2012

With initial angel investment, we successfully launched our first Class C cleanroom manufacturing facility in biotech hub of Shanghai.

2015

LePure Biotech has been honored with the prestigious recognition as a nationally acclaimed high-tech enterprise

2019

Our groundbreaking “Special Nutrient Storage Solution and Products for Outer Space Breeding” embarked on an historic journey alongside China’s Chang’e 4 mission to the Moon.

In the same year, LePure Biotech received the Shanghai Songjiang Science and Technology Innovation Award.

2021

Achieved a significant milestone with the establishment of its state-of-the-art US-based R&D center in Massachusetts. Additionally, the company garnered substantial investments from top-tier investors such as Legend Capital and Hillhouse China, further fortifying its industry presence.

2022

LePure Biotech’s strategic acquisitions of Geshi Filter and QuaCell Biotech have transformed it into a leading biotechnology solutions provider, seamlessly integrating pharmaceutical filtration technology and cell culture development expertise. The company has gained the support of top-tier investors such as NOVO, GA, and GS, while also achieving dual ISO13485 and ISO9001 certifications. LePure Biotech’s outstanding growth was further acknowledged with the Shanghai Hundreds Growing Business award, cementing its position as an industry leader.

2023

Acquisition of Sterist and the subsequent integration of comprehensive clean management solutions have significantly broadened the company’s business portfolio.

Bioprocess Solution

Our production process enables us to optimize costs without compromising on the quality of our single-use equipment and consumables. LePure Biotech remains dedicated to delivering cost-effective solutions without compromising the cutting-edge technology and reliability that we are renowned for.